Northwestern Medicine doc talks new FDA-approved Alzheimer’s drug with WGN

Northwestern Medicine doc talks new FDA-approved Alzheimer’s drug with WGN

Dr. Marsel Mesulam, director of the Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern Medicine, spoke with WGN about the FDA-approved drug to treat early-stage Alzheimer’s.